Literature DB >> 9620364

Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics.

J Lew1, P Reichelderfer, M Fowler, J Bremer, R Carrol, S Cassol, D Chernoff, R Coombs, M Cronin, R Dickover, S Fiscus, S Herman, B Jackson, J Kornegay, A Kovacs, K McIntosh, W Meyer, N Michael, L Mofenson, J Moye, T Quinn, M Robb, M Vahey, B Weiser, T Yeghiazarian.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9620364      PMCID： PMC104860     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  35 in total

1.  Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group.

Authors:  W T Shearer; T C Quinn; P LaRussa; J F Lew; L Mofenson; S Almy; K Rich; E Handelsman; C Diaz; M Pagano; V Smeriglio; L A Kalish
Journal:  N Engl J Med       Date:  1997-05-08       Impact factor: 91.245

2.  Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina.

Authors:  S B Mostad; J Overbaugh; D M DeVange; M J Welch; B Chohan; K Mandaliya; P Nyange; H L Martin; J Ndinya-Achola; J J Bwayo; J K Kreiss
Journal:  Lancet       Date:  1997-09-27       Impact factor: 79.321

3.  Longitudinal analysis of quantitative virologic measures in human immunodeficiency virus-infected subjects with > or = 400 CD4 lymphocytes: implications for applying measurements to individual patients. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.

Authors:  W B Paxton; R W Coombs; M J McElrath; M C Keefer; J Hughes; F Sinangil; D Chernoff; L Demeter; B Williams; L Corey
Journal:  J Infect Dis       Date:  1997-02       Impact factor: 5.226

4.  Comparison of serum and plasma viral RNA measurements in primary and chronic human immunodeficiency virus type 1 infection.

Authors:  R J Rodriguez; D E Dayhoff; G Chang; S A Cassol; D L Birx; A W Artenstein; N L Michael
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-05-01

5.  Quantification of human immunodeficiency virus type 1 RNA from dried plasma spots collected on filter paper.

Authors:  S Cassol; M J Gill; R Pilon; M Cormier; R F Voigt; B Willoughby; J Forbes
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

6.  Effects of specimen collection, processing, and storage conditions on stability of human immunodeficiency virus type 1 RNA levels in plasma.

Authors:  C C Ginocchio; X P Wang; M H Kaplan; G Mulligan; D Witt; J W Romano; M Cronin; R Carroll
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

7.  Absolute copy number and relative change in determinations of human immunodeficiency virus type 1 RNA in plasma: effect of an external standard on kit comparisons.

Authors:  D Brambilla; S Leung; J Lew; J Todd; S Herman; M Cronin; D E Shapiro; J Bremer; C Hanson; G V Hillyer; G D McSherry; R S Sperling; R W Coombs; P S Reichelderfer
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

8.  The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.

Authors:  L M Mofenson; J Korelitz; W A Meyer; J Bethel; K Rich; S Pahwa; J Moye; R Nugent; J Read
Journal:  J Infect Dis       Date:  1997-05       Impact factor: 5.226

9.  Influence of other maternal variables on the relationship between maternal virus load and mother-to-infant transmission of human immunodeficiency virus type 1.

Authors:  D N Burns; S Landesman; D J Wright; D Waters; R M Mitchell; A Rubinstein; A Willoughby; J J Goedert
Journal:  J Infect Dis       Date:  1997-05       Impact factor: 5.226

10.  Natural history of HIV-1 cell-free viremia.

Authors:  D R Henrard; J F Phillips; L R Muenz; W A Blattner; D Wiesner; M E Eyster; J J Goedert
Journal:  JAMA       Date:  1995-08-16       Impact factor: 56.272
View more
  22 in total

1.  Obtaining unacceptable results in assays for quantitation of human immunodeficiency virus type 1 RNA in plasma samples.

Authors:  A Aguilera; A Vela; M Treviño; E Varela; R Seoane; B J Regueiro
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Comparison of blood collected in acid-citrate-dextrose and EDTA for use in human immunodeficiency virus peripheral blood mononuclear cell cultures.

Authors:  S A Fiscus; H Chakraborty; R Shepard; M Goodman
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Assessment of agreement between the AMPLICOR HIV-1 MONITOR test versions 1.0 and 1.5.

Authors:  Charles E Hill; Alicia M Green; Jessica Ingersoll; Kirk A Easley; Frederick S Nolte; Angela M Caliendo
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

4.  Efficient quantification of HIV-1 in heparin plasma spiked with cultured HIV-1 by the Roche Cobas TaqMan and Abbott RealTime HIV-1 tests.

Authors:  Linda L Jagodzinski; Holly R Weston; Ying Liu; Robert J O'Connell; Sheila A Peel
Journal:  J Clin Microbiol       Date:  2012-06-06       Impact factor: 5.948

5.  Intra- and interlaboratory variabilities of results obtained with the Quantiplex human immunodeficiency virus type 1 RNA bDNA assay, version 3.0.

Authors:  J A Kellogg; P V Atria; J C Sanders; M E Eyster
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

6.  Stability of hepatitis C virus, HIV, and hepatitis B virus nucleic acids in plasma samples after long-term storage at -20°C and -70°C.

Authors:  Cristina Baleriola; Harpreet Johal; Brendan Jacka; Sandra Chaverot; Scott Bowden; Sara Lacey; William Rawlinson
Journal:  J Clin Microbiol       Date:  2011-07-13       Impact factor: 5.948

7.  Optimizing screening for acute human immunodeficiency virus infection with pooled nucleic acid amplification tests.

Authors:  Daniel J Westreich; Michael G Hudgens; Susan A Fiscus; Christopher D Pilcher
Journal:  J Clin Microbiol       Date:  2008-03-19       Impact factor: 5.948

8.  Comparison of NucliSens and Roche Monitor assays for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma.

Authors:  J R Dyer; C D Pilcher; R Shepard; J Schock; J J Eron; S A Fiscus
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

9.  Simultaneous Treatment of Missing Data and Measurement Error in HIV Research Using Multiple Overimputation.

Authors:  Michael Schomaker; Sara Hogger; Leigh F Johnson; Christopher J Hoffmann; Till Bärnighausen; Christian Heumann
Journal:  Epidemiology       Date:  2015-09       Impact factor: 4.822

10.  Stability of human immunodeficiency virus type 1 RNA in cerebrospinal fluid determined with the AMPLICOR HIV-1 MONITOR test, version 1.5 (ultrasensitive).

Authors:  Elyse J Singer; H Aaron Aronow; Shing-Yi Lee; Charles H Hinkin; Tadd Lazarus
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.